ZNF667 Alleviates the Inflammatory Damage in Intervertebral Disc Degeneration Via Inhibiting NF-κB Signaling Pathway

Overview

Journal Zhong Nan Da Xue Xue Bao Yi Xue Ban

Specialty General Medicine

Date 2025 Mar 12

PMID 40074310

Authors

Hua Zhong

Lebin Guo

Yan Yang

Chenjun Tian

Fusheng Liu

Bowen Zheng

Affiliations

Soon will be listed here.

Abstract

Objectives: With the aging population, the incidence of intervertebral disc degeneration (IDD) is increasing every year. The pathogenesis of IDD is complex, and there are currently no effective treatment options. This study aims to investigate the specific function and underlying mechanism of zinc finger protein 667 (ZNF667) in the inflammatory damage of nucleus pulposus cells in IDD.

Methods: Differential expression genes (DEG) associated with IDD were screened from IDD-related datasets in the Gene Expression Omnibus (GEO) (GSE124272 and GSE150408), and ZNF667, which is closely related to gene transcriptional regulation, was selected and analyzed in several IDD-related datasets (GSE124272, GSE150408, GSE56081, GSE147383, GSE23130). Nucleus pulposus tissues were collected from 3 IDD patients and 3 trauma-induced vertebral fracture patients (serving as controls). Hematoxylin and eosin (HE) staining was performed for pathological examination, and immunohistochemistry (IHC) was used to assess ZNF667 expression in the nucleus pulposus tissues. Gene set enrichment analysis (GSEA) was then employed to elucidate the potential mechanisms of ZNF667. For in vitro validation, human primary nucleus pulposus cells were treated with 10 ng/mL of interleukin-1β (IL-1β) to establish an IDD cell model, and subsequently transfected with a ZNF667 overexpression plasmid. Flow cytometry was used to evaluate cell apoptosis, enzyme-linked immunosorbent assay (ELISA) measured the levels of inflammatory factors-cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the cell culture supernatant, real-time polymerase chain reaction (RT-PCR) quantified mRNA expression, and Western blotting assessed protein expression levels of ZNF667, myeloid differentiation factor 88 (MyD88), P65, and phosphorylated P65 (p-P65).

Results: Analysis of both the GEO datasets and clinical tissue samples revealed that ZNF667 expression is reduced in IDD. In IDD patients, the extracellular matrix and nucleus pulposus cells are significantly diminished, and the arrangement of fibrochondrocytes is disordered. GSEA results showed that ZNF667 may be involved in biological processes such as angiogenesis, epithelial-mesenchymal transition (EMT), oxidative phosphorylation, peroxisome function, steroid biosynthesis, and the NF-κB-mediated TNF-α signaling pathway. In vitro, ZNF667 was expressed at low levels in the IL-1β-induced IDD cell model, and overexpression of ZNF667 reversed the IL-1β-induced increase in cell apoptosis, the upregulation of inflammation factors (COX-2, IL-6, TNF-α), and the increased expression of NF-κB pathway-related proteins (MyD88 and the p-P65/P65 ratio) (all <0.05).

Conclusions: ZNF667 can alleviate nucleus pulposus cell apoptosis and inflammatory responses by inhibiting the NF-κB signaling pathway, thereby exerting a protective effect on intervertebral discs. This finding not only provides new insights into the pathogenesis of IDD but also suggests a potential therapeutic target for its treatment.

References

Vilas C, Emery L, Denchi E, Miller K . Caught with One's Zinc Fingers in the Genome Integrity Cookie Jar. Trends Genet. 2018; 34(4):313-325. PMC: 5878116. DOI: 10.1016/j.tig.2017.12.011. View

Kwon K, Chae H . Sodium salicylate inhibits expression of COX-2 through suppression of ERK and subsequent NF-kappaB activation in rat ventricular cardiomyocytes. Arch Pharm Res. 2003; 26(7):545-53. DOI: 10.1007/BF02976879. View

Fang F, Jiang D . IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells. Biosci Rep. 2016; 36(5). PMC: 5025813. DOI: 10.1042/BSR20160118. View

Zhao F, Guo Z, Hou F, Fan W, Wu B, Qian Z . Magnoflorine Alleviates "M1" Polarized Macrophage-Induced Intervertebral Disc Degeneration Through Repressing the HMGB1/Myd88/NF-κB Pathway and NLRP3 Inflammasome. Front Pharmacol. 2021; 12:701087. PMC: 8343137. DOI: 10.3389/fphar.2021.701087. View

Huang B, Zheng L, Wei X, Zheng Z, Wu H, Chen J . Activation of Nrf2 signaling by 4-octyl itaconate attenuates the cartilaginous endplate degeneration by inhibiting E3 ubiquitin ligase ZNF598. Osteoarthritis Cartilage. 2022; 31(2):213-227. DOI: 10.1016/j.joca.2022.10.008. View

Xin J, Wang Y, Zheng Z, Wang S, Na S, Zhang S . Treatment of Intervertebral Disc Degeneration. Orthop Surg. 2022; 14(7):1271-1280. PMC: 9251272. DOI: 10.1111/os.13254. View

Yuan Q, Wang X, Liu L, Cai Y, Zhao X, Ma H . Exosomes Derived from Human Placental Mesenchymal Stromal Cells Carrying AntagomiR-4450 Alleviate Intervertebral Disc Degeneration Through Upregulation of ZNF121. Stem Cells Dev. 2020; 29(16):1038-1058. DOI: 10.1089/scd.2020.0083. View

Zhang Y, Yi W, Xia H, Lan H, Chen J, Yang Z . A20 regulates inflammation through autophagy mediated by NF-κB pathway in human nucleus pulposus cells and ameliorates disc degeneration in vivo. Biochem Biophys Res Commun. 2021; 549:179-186. DOI: 10.1016/j.bbrc.2021.02.115. View

Krut Z, Pelled G, Gazit D, Gazit Z . Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration. Cells. 2021; 10(9). PMC: 8471333. DOI: 10.3390/cells10092241. View

10.

Li Y, Chao R, Qu S, Huang L, Zhang C . ZNF667 Suppressed LPS-induced Macrophages Inflammation through mTOR-dependent Aerobic Glycolysis Regulation. Curr Pharm Des. 2023; 29(17):1361-1369. DOI: 10.2174/1381612829666230530143129. View

11.

Shao Z, Wang B, Shi Y, Xie C, Huang C, Chen B . Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis. Osteoarthritis Cartilage. 2020; 29(3):413-422. DOI: 10.1016/j.joca.2020.11.006. View

12.

Tung Y, Wei C, Yen C, Lee P, Ware L, Huang H . Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway. Front Pharmacol. 2022; 12:793107. PMC: 8802116. DOI: 10.3389/fphar.2021.793107. View

13.

Gong Y, Qiu J, Jiang T, Li Z, Zhang W, Zheng X . Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis. Inflammopharmacology. 2022; 31(1):369-384. PMC: 9957850. DOI: 10.1007/s10787-022-01098-5. View

14.

Yu H, Lin L, Zhang Z, Zhang H, Hu H . Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020; 5(1):209. PMC: 7506548. DOI: 10.1038/s41392-020-00312-6. View

15.

Kloppenburg M, Berenbaum F . Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthritis Cartilage. 2020; 28(3):242-248. DOI: 10.1016/j.joca.2020.01.002. View

16.

Kishore R, Arnaboldi V, Van Slyke C, Chan J, Nash R, Urbano J . Automated generation of gene summaries at the Alliance of Genome Resources. Database (Oxford). 2020; 2020. PMC: 7304461. DOI: 10.1093/database/baaa037. View